Purchase this article with an account.
S. Bagai, A. Jian-Amadi, D. Garcia; Evaluation of ENDURAGen for Lower Lid Retraction Repair. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4822.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate lower eyelid retraction repair using ENDURAGen for augmenting the posterior lamella.
A retrospective chart review of patients undergoing lower eyelid retraction repair using ENDURAGen over the last year. All cases performed by the same surgeon. Objective measurements of inferior scleral show, and lagophthalmos were noted. Mean follow up interval time of 3 months (range 1month to 6months). Six patients were identified with repair of total of nine lower eyelids. Complication and patient satisfaction was also noted. The main outcome measures were objective measurements of lagophthalmos and scleral show.
Out of six patients, a total of nine procedures were performed. Four out of nine had satisfactory results, with no inferior scleral show or lagophthalmos. One patient had trace inferior scleral show attributed to the dehiscence of the lateral cantus suspension and planning to be addressed with a secondary lateral canthoplasty. Two patients had some inflammation causing a mechanical entropion, one of whom was treated with Kenalog with satisfactory results. One patient with a bilateral procedure was lost to follow-up---mccaden. One patient also with a bilateral procedure had some mild inflammation with a follicular reaction, and was started on Fluorometholone drops. Mean follow up interval time of 3 months with a range from 1 month to 6months was noted.
Based on our preliminary evaluation ENDURAGen shows promise as an augmentation alternative to harvesting of autologous tissue. Improvement was noted in the inferior scleral show without evidence of lagophthalmos. Further long term follow-up is required to elucidate retention of the results.
This PDF is available to Subscribers Only